2023-507226-16-00CompletedPhase 4
Bioequivalence clinical trial of two formulations of ezetimibe/atorvastatin
Laboratorios Normon S.A.1 site in 1 country36 target enrollmentStarted: September 6, 2023Last updated:
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Enrollment
- 36
- Locations
- 1
Study Overview
Brief Summary
No summary available.
Eligibility Criteria
- Ages
- 18 years to 64 years (18-64 Years)
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Carlos Govantes (R&D Director)
Scientific
Laboratorios Normon S.A.
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 4
Bioequivalence clinical trial of two formulations of linagliptin/metformin2024-515076-13-00Laboratorios Normon S.A.48
Completed
Phase 1
A Study to Compare Blood Levels of Different Dosage Formulations of the Study Medicine That Is a CGRP Receptor Antagonist in Healthy AdultsNCT07261371Pfizer64
Completed
Phase 4
Bioequivalence study of a proposed biosimilar insulin glargine U300 with Toujeo®Type 1 Diabetes Mellitus2023-504509-36-00Biocon Sdn. Bhd.68
Recruiting
Phase 4
Randomised, crossover bioequivalence clinical trial of escitalopram 10 mg capsules versus escitalopram 10 mg film-coated tablets, after a single oral dose administration to healthy volunteers under fasting conditions.2025-522124-26-00Laboratorios Alter S.A.36
Completed
Phase 4
Randomised, crossover bioequivalence clinical trial of apixaban 5 mg film-coated tablets, after a single oral dose administration to healthy volunteers under fasting conditions2023-503557-35-00Alter Farmacia S.A.24